Elevance Health, Inc.
AT ˙ WBAG
SecurityAT:ELV / Elevance Health, Inc.
InstitutionTompkins Financial Corp
Latest Disclosed Ownership9 shares
Latest Disclosed Value $ 2,635
Tompkins Financial Corp reports 68.97% decrease in ownership of ELV / Elevance Health, Inc.

On April 9, 2026 - Tompkins Financial Corp filed a 13F-HR form disclosing ownership of 9 shares of Elevance Health, Inc. (AT:ELV) valued at $2,635 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 29 shares of Elevance Health, Inc.. This represents a change in shares of -68.97% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 9 -20 -68.97 3 -80.00 0.0002
2026-01-08 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 29 0 0.00 10 11.11 0.0008
2025-10-08 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 29 0 0.00 9 -18.18 0.0008
2025-07-10 2025-06-30 13F ELEVANCE HEALTH COM 036752103 29 -50 -63.29 11 -67.65 0.0010
2025-04-07 2025-03-31 13F ELEVANCE HEALTH COM 036752103 79 20 33.90 34 61.90 0.0033
2025-01-15 2024-12-31 13F Elevance Health COM 036752103 59 0 0.00 22 -30.00 0.0020
2024-11-01 2024-09-30 13F Elevance Health COM 036752103 59 0 0.00 31 -3.23 0.0029
2024-07-17 2024-06-30 13F Elevance Health COM 036752103 59 0 0.00 32 3.33 0.0033
2024-04-08 2024-03-31 13F Elevance Health COM 036752103 59 0 0.00 31 11.11 0.0035
2024-01-08 2023-12-31 13F Elevance Health COM 036752103 59 0 0.00 28 8.00 0.0034
2023-11-21 2023-09-30 13F Elevance Health COM 036752103 59 0 0.00 26 -3.85 0.0040
2023-07-12 2023-06-30 13F Elevance Health COM 036752103 59 0 0.00 26 -3.70 0.0041
2023-04-20 2023-03-31 13F Elevance Health COM 036752103 59 0 0.00 27 0.0044
2023-01-06 2022-12-31 13F Elevance Health COM 036752103 59 0 0.00 0 -100.00 0.0047
2022-10-13 2022-09-30 13F Elevance Health COM 036752103 59 0 0.00 27 -3.57 0.0046
2022-07-14 2022-06-30 13F Elevance Health COM 036752103 59 0 0.00 28 -3.45 0.0045
2022-05-12 2022-03-31 13F Anthem COM 036752103 59 0 0.00 29 7.41 0.0041
2022-01-24 2021-12-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 59 0 0.00 27 22.73 0.0048
2021-10-22 2021-09-30 13F ANTHEM EQUITIES/EXCHANGE TRADED FUNDS 036752103 59 9 18.00 22 22.22 0.0040
2021-06-09 2021-03-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 50 0 0.00 18 12.50 0.0030
2021-02-12 2020-12-31 13F/A-1 ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 50 0 0.00 16 23.08 0.0029
2021-02-05 2020-12-31 13F ANTHEM, INC. COM US LARGE-CAP EQUITIES 036752103 21,824 21,774 4,954 208,535.7373
2020-10-23 2020-09-30 13F ANTHEM EQUITIES/EXCHANGE TRADED FUNDS 036752103 50 0 0.00 13 0.00 0.0025
2020-07-29 2020-06-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 50 -182 -78.45 13 -75.47 0.0027
2020-04-22 2020-03-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 232 -30 -11.45 53 -32.91 0.0122
2020-01-22 2019-12-31 13F/A-1 ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 262 262 79 0.0145
2017-07-11 2017-06-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 0 -2,558 -100.00 0 -100.00
2017-04-17 2017-03-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 2,558 2,558 356 0.1125
2016-10-13 2016-09-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 0 -2,060 -100.00 0 -100.00
2016-07-13 2016-06-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 2,060 -498 -19.47 271 -23.88 0.0802
2016-04-20 2016-03-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 2,558 0 0.00 356 -0.28 0.1125
2016-01-19 2015-12-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 2,558 2,060 413.65 357 410.00 0.1137
2015-10-16 2015-09-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 498 0 0.00 70 -14.63 0.0226
2015-07-14 2015-06-30 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 498 -2 -0.40 82 6.49 0.0223
2015-04-21 2015-03-31 13F/A-1 ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 500 0 0.00 77 22.22 0.0193
2015-04-14 2015-03-31 13F ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 500 77
2015-01-15 2014-12-31 13F/A-1 ANTHEM INC COM EQUITIES/EXCHANGE TRADED FUNDS 036752103 500 500 63 0.0157
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.